PharmaLectures.com

Courses › Country and business playbooks › Selling into Europe as a finished-dose generic company from Korea

Selling into Europe as a finished-dose generic company from Korea

Get your Korean generics approved in Europe and on pharmacy shelves without rework.

  • 12 audio modulesthree lengths each
  • 2 h to 10 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Korea, Finished-dose generic companywho it is written for

Why this training matters

Your European importer opens the batch file just before certification and finds the Korean records do not match the dossier. The Qualified Person will not sign. The batch waits in a warehouse, the distributor's order lapses, and your launch slips a quarter.

What changes after this course

Your team files dossiers that match your batch records, answers inspectors from documents already on the shelf, and picks the right procedure before the first partner call. You hold a certificate for each learner and a training record for each person.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory affairs team chooses between the Decentralised Procedure, Mutual Recognition and the Centralised Procedure in one sitting, without asking legal. They write Common Technical Document Module 3 so the assessor finds each answer where expected, and a Request for Information becomes a short reply instead of a month of searching.

Quality managers open Chapter 1 of EudraLex Volume 4 and see which of your procedures already comply and which need a rewrite. International Council for Harmonisation Q10 stops being a slogan on the wall. When an auditor asks for a deviation record, the file is in the room, and your importer's Qualified Person has what Annex 16 requires.

Safety staff know the reporting clock for a serious adverse reaction and who starts it. They feed your European Qualified Person for Pharmacovigilance and the Pharmacovigilance System Master File under Good Pharmacovigilance Practice. Logistics adds the safety features required by the Falsified Medicines Directive before the packaging line is booked, so the first shipment is not turned away.

Executives walk into a distributor meeting already knowing how reference pricing and national reimbursement lists work. Variations under Commission Regulation 1234/2008 are sorted into Type IA, Type IB or Type II before anyone files. The launch plan rests on statutory timelines and a real inspection calendar instead of hope.

Who needs this training

  • Regulatory Affairs Manager

    A Request for Information arrives and the launch date moves. Afterwards they build Module 3 to match the batch records and choose the procedure before the first partner call.

  • Quality Assurance Director

    An inspector asks for the Site Master File and the latest deviation records on the first morning. They have both ready, written to Chapter 1 of EudraLex Volume 4.

  • Pharmacovigilance Officer

    A serious adverse reaction report reaches the Korean office on a Friday. They know who starts the clock, what the European Qualified Person for Pharmacovigilance needs, and what Good Pharmacovigilance Practice expects.

  • Supply Chain Operations Lead

    A first pallet sits at the distributor's dock because the pack lacks its safety features. They check the Falsified Medicines Directive requirements before the packaging run, not after it.

  • Business Development Director

    Before a pricing call with a distributor, they know how reference pricing and reimbursement lists work in each target country, and how long a launch really takes.

Roles: Owner, CEO and board, Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: Finished-dose generic company

Countries: Korea

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Choose between the Decentralised, Mutual Recognition and Centralised Procedures for a given generic product and defend the choice with the statutory timeline.
  2. Lay out Common Technical Document Module 3 so each quality question has its answer in the section where the assessor looks.
  3. Compare your quality manual with Chapter 1 of EudraLex Volume 4 and list the procedures that need rewriting.
  4. State the reporting deadline for a serious adverse reaction and name who in your company starts the clock.
  5. Sort a manufacturing change into Type IA, Type IB or Type II under Commission Regulation 1234/2008.
  6. Write an inspection deficiency response that addresses the cause, the correction and the follow-up check.
  7. Check a pack design against the Falsified Medicines Directive safety features before printing begins.

What the company gets

  • Dossiers reach the national authorities with Module 3 matching your batch records, so fewer weeks go to answering avoidable questions.
  • An inspector asking about deviation management or the Site Master File gets a straight answer from a document that is already on file.
  • Your European importer and distributor receive packs with the Falsified Medicines Directive safety features and the paperwork they need to accept the shipment.
  • Each learner holds a certificate and a training record, so a buyer's due diligence team or an auditor sees proof of competence immediately.
  • Variations are filed in the right category the first time, which protects the sale of the changed product.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 12 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard5 h25 min a module, for regulatory, quality and business-development staff
Expanded10 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing2 h
Business development and export salesBriefing2 h
Regulatory affairsStandard5 h
Quality assurance and Qualified PersonStandard5 h

Course outline: 12 modules

12 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Choose your first European Union markets for your Korean generics

    • How to tell which decisions belong to the European Medicines Agency and which to each country.
    • Why one European plan for twenty-seven member states stalls, and what to draw up instead.
    • The market data that shows which countries already prefer generics, so your first filing goes there.
  2. 2Apply Directive 2001/83/EC to decide what your dossier must contain

    • Why Article 10 of Directive 2001/83/EC lets your dossier lean on the reference product's data.
    • How the same directive reads differently once each member state writes it into national law.
    • What to do when a national rule contradicts your Korean practice and the dossier is already half written.
  3. 3Pick the fastest marketing authorisation procedure for your dossier

    • When the Decentralised Procedure fits your first filing and when Mutual Recognition is the faster road.
    • The check that tells you whether your product must use the Centralised Procedure or may avoid it.
    • How to lay your submission date against the statutory clock of each route so partners get a real date.
  4. 4Bring your plant into line with European Good Manufacturing Practice Part I

    • The chapters of Part I that matter most to a plant outside Europe and what to fix first.
    • How your European importer's Qualified Person reaches batch certification without waiting on your records.
    • Why Annex 1 changes how you plan sterile lines, and which parts do not concern an oral solid plant.
  5. 5Build a quality system that passes EudraLex audits

    • How Chapter 1 of EudraLex Volume 4 turns your Korean quality manual into one the inspector recognises.
    • How International Council for Harmonisation Q10 fits your existing procedures so you rewrite less.
    • What to do when an auditor asks for the last three deviations and the proof each one closed.
  6. 6Compile a Common Technical Document Module 3 that avoids rejections

    • How to lay out Module 3 so the assessor finds each answer where they look for it.
    • Why a mismatch between your Korean batch records and the dossier draws a question, and how to prevent it.
    • What to do when a Request for Information lands in your inbox and your launch date is at stake.
  7. 7Run a pharmacovigilance system that meets European reporting deadlines

    • How to give your European Qualified Person for Pharmacovigilance the data they need on day one.
    • The reporting clock for a serious adverse reaction, and how a report from Korea reaches your European marketing authorisation holder.
    • What the Pharmacovigilance System Master File must show, and where your local team feeds it.
  8. 8Secure your supply chain under the Falsified Medicines Directive

    • How to place the unique identifier and anti-tampering device on your packs before the line is booked.
    • The paperwork your European distributor asks for before accepting a first shipment.
    • How Good Distribution Practice shapes what your logistics team must hand over when a European partner holds the licence.
  9. 9Price your generics to win a place on national reimbursement lists

    • Why marketing authorisation does not put your generic on a single national reimbursement list.
    • How reference pricing and tendering decide what a country pays for a generic, before you quote.
    • What to do when the national price offer falls below the cost of shipping from Korea.
  10. 10File variations under Commission Regulation 1234/2008 without delays

    • How to sort a manufacturing change into Type IA, Type IB or Type II before you file.
    • Why filing a change in the wrong category can stop the changed product from being sold.
    • The renewal file for the five-year mark, ready before the reminder arrives.
  11. 11Pass national authority Good Manufacturing Practice inspections

    • The Site Master File pages an inspector reads before arriving, and how to make them clear.
    • How to write a deficiency response that closes the finding instead of opening a second one.
    • What to do on inspection day when the inspector heads straight to your warehouse.
  12. 12Plan your European market entry around real regulatory timelines

    • How to sequence national launches so your Korean plant is not asked for more than it can pack.
    • The warning signs in a distribution partner's first answers that show a slow launch ahead.
    • What the road from dossier submission to first sale looks like, step by step, with a real calendar.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

12 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h in the briefing length and 10 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Korea, Finished-dose generic company. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 108 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team